23948sdkhjf
Logga in eller skapa en prenumeration för att spara artiklar
Få tillgång till allt innehåll på Medtech Magazine
Ingen bindningstid eller kortinformation krävs
Gäller endast personlig prenumeration.
Kontakta oss för en företagslösning.
Annons
Annons
Innehållet nedan modereras inte i förväg och omfattas därmed inte av webbplatsens utgivningsbevis.
Dela sida
Sponsrat innehåll

QAdvis & Scandinavian CRO are now Aurevia

Two years ago, we became part of something bigger.

At first, the change was mostly visible on paper — a new owner and later a new name: Aurevia. But this was never just about ownership or branding. It was about strengthening what we already do well — and unlocking new possibilities for the future.

Built on a strong foundation
Our reputation has always been built on close relationships, deep expertise, and a clear focus on delivering value to our customers. That foundation hasn’t changed. If anything, it has become even more important.

Stronger together
Becoming Aurevia has given us access to broader knowledge, expanded resources, and new perspectives. This allows us to support our customers with deeper expertise, greater capacity, and more opportunities to grow together.

Our name has changed, but our commitment hasn’t.
You’ll still meet the same people with the same dedication.
And now, you’ll gain more insight, innovation, and new ways forward.

Because this was never just a name change.
It’s a step towards something better. 

Contact us to learn more about our quality, regulatory and clinical research services.

Aurevia
Box 150 27
750 15 Uppsala
Uppsala kommun
Sverige
VAT nummer: SE5565873147

Kontaktperson

Ulrika Hammarström
Head of CRO
ulrika.hammarstrom@aurevia.com
Annons Annons
BREAKING
{{ article.headline }}
0.031|instance-web02